Latest Close
$3.11
News
RXRX
Recursion Pharmaceuticals, Inc. News
This news view pulls recent coverage and headlines tied to RXRX.
1y Change
-$1.70 (-35.34%)
Market Cap
$1.64B
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
Recursion Pharmaceuticals (RXRX) Beats Stock Market Upswing: What Investors Need to Know
Zacks • Apr 2, 2026
Read articleExpanded Citeline Data Partnership and CMO Transition Could Be A Game Changer For Recursion Pharmaceuticals (RXRX)
Simply Wall St. • Apr 2, 2026
Read articleRecursion Pharmaceuticals, Citeline Expand Partnership
MT Newswires • Mar 31, 2026
Read articleRecursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform
GlobeNewswire • Mar 31, 2026
Read article2 AI Healthcare Stocks to Buy Right Now
Motley Fool • Mar 31, 2026
Read articleMRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI’s 2026 Performance
24/7 Wall St. • Mar 29, 2026
Read article